Patricia Pavlinac, MS, PhD

Assistant Professor, Global Health

Adjunct Assistant Professor, Epidemiology

 

Dr. Patricia Pavlinac, MS, PhD, is an epidemiologist and Assistant Professor in the Department of Global Health at the University of Washington. Dr. Pavlinac also co-directs the Gut Health and Child Survival scientific priority area of the Global Center for Integrated Health of Women, Adolescents and Children (Global WACh). Her research aims to identify interventions to halt morbidity and mortality attributed to enteric infectious diseases in children. Dr. Pavlinac has extensive experience coordinating pediatric studies in Kenya including her current role as Project Director of two clinical trials testing whether empiric use of a broad-spectrum antibiotic improves post-acute survival and growth in Kenyan children. These trials build on evidence that Kenyan children suffer an elevated risk of mortality and chronic malnutrition after acute infectious illnesses that may be due to inadequately treated or new exposure to bacterial pathogens. Nested in these trials, her team is also evaluating the impact of azithromycin on antimicrobial resistance to provide policy-makers with a balanced perspective on the costs and benefits of empiric azithromycin use. 

Publications

  1. Horne, B, Otieno Onyando, B, Badji, H, Mujahid, W, Bhuiyan, TR, Bakali, M et al.. Fecal biomarkers to characterize intestinal inflammation among children with medically attended diarrhea across six low-resource settings: Findings from the Enterics for Global Health (EFGH) Shigella surveillance study. PLoS Negl Trop Dis. 2026;20 (9):e0014320. doi: 10.1371/journal.pntd.0014320. PubMed PMID:42743324 PubMed Central PMC13592711.
  2. Schiaffino, F, Parker, CT, Romaina Cachique, L, Garcia Bardales, PF, Liu, J, Peñataro Yori, P et al.. Robust performance of culture, real-time PCR, and genomic approaches for shigella serotyping in a pediatric surveillance cohort. PLoS Negl Trop Dis. 2026;20 (8):e0014668. doi: 10.1371/journal.pntd.0014668. PubMed PMID:42647588 PubMed Central PMC13614632.
  3. McQuade, ETR, Codi, A, Pavlinac, PB, Feutz, E, Kotloff, K, Platts-Mills, JA et al.. Effects of Shigella diarrhea with and without antibiotic treatment on linear growth: an individual patient data meta-analysis of five multisite studies among children in low-resource settings. medRxiv. 2026; :. doi: 10.64898/2026.07.10.26357688. PubMed PMID:42528504 PubMed Central PMC13409227.
  4. Ahmed, N, Yousafzai, MT, Rao, SI, Means, AR, Pavlinac, PB, Morozoff, C et al.. Exploring risk factors associated with catastrophic health expenditure on diarrhea management in Karachi, Pakistan, 2022-2024. PLOS Glob Public Health. 2026;6 (7):e0005391. doi: 10.1371/journal.pgph.0005391. PubMed PMID:42455800 PubMed Central PMC13372140.
  5. Oreso, C, Ogwel, B, Awuor, AO, Anyango, RO, Kotloff, K, Hossain, MJ et al.. Frequency and correlates of non-receipt of age-appropriate vaccination among children aged 6-35 months with medically attended diarrhea: Findings from the Enterics for Global Health (EFGH) Shigella study, 2022-2024. PLOS Glob Public Health. 2026;6 (7):e0005670. doi: 10.1371/journal.pgph.0005670. PubMed PMID:42384629 PubMed Central PMC13322521.
Search PubMed